中国医学装备
中國醫學裝備
중국의학장비
CHINA MEDICAL EQUIPMENT
2014年
1期
17-19,20
,共4页
吴莺%高悦%王燕%金志春%郭鹏
吳鶯%高悅%王燕%金誌春%郭鵬
오앵%고열%왕연%금지춘%곽붕
子宫肌瘤%高强度聚焦超声%疗效
子宮肌瘤%高彊度聚焦超聲%療效
자궁기류%고강도취초초성%료효
Hysteromyoma%High intensity focused ultrasound%Curative effect
目的:分析单次整体体外超声消融治疗子宫肌瘤效果不佳的原因和解决的办法。方法:对子宫肌瘤单次整体高强度聚焦超声(HIFU)治疗效果不佳后行手术治疗的5例患者治疗资料及术中所见、术后组织病理检查结果进行回顾性分析,并复习相关文献。结果:本组HIFU治疗平均功率362~400 W、辐照时间998~2947 s、治疗剂量398500.0J~1178800.0J、治疗强度789~1091 s/h;HIFU治疗后11~16个月症状改善不明显,核磁共振检查或超声检查提示瘤体未明显缩小或稍增大,HIFU治疗后至手术时间为11~22个月;其中4例患者行子宫肌瘤剔除手术,1例患者行全子宫切除术。超声所见:子宫浆膜层光滑,与盆腔脏器、腹膜均无粘连,受照子宫肌瘤病灶中心1/2~4/5区域均为灰白色干酪样或乳状坏死,瘤体表层1/5部位见粉色典型螺旋状平滑肌组织结构、质地较软,部分呈囊性变;子宫浆膜层、子宫肌层及子宫内膜外观正常。术后病理检查提示:瘤体组织为平滑肌组织或有透明变性,无恶性病变组织。结论:肌瘤的部位、瘤体血供及治疗能量是影响HIFU疗效的重要因素,个体化治疗是HIFU成功的原则,彩色多普勒检测具有指导意义。
目的:分析單次整體體外超聲消融治療子宮肌瘤效果不佳的原因和解決的辦法。方法:對子宮肌瘤單次整體高彊度聚焦超聲(HIFU)治療效果不佳後行手術治療的5例患者治療資料及術中所見、術後組織病理檢查結果進行迴顧性分析,併複習相關文獻。結果:本組HIFU治療平均功率362~400 W、輻照時間998~2947 s、治療劑量398500.0J~1178800.0J、治療彊度789~1091 s/h;HIFU治療後11~16箇月癥狀改善不明顯,覈磁共振檢查或超聲檢查提示瘤體未明顯縮小或稍增大,HIFU治療後至手術時間為11~22箇月;其中4例患者行子宮肌瘤剔除手術,1例患者行全子宮切除術。超聲所見:子宮漿膜層光滑,與盆腔髒器、腹膜均無粘連,受照子宮肌瘤病竈中心1/2~4/5區域均為灰白色榦酪樣或乳狀壞死,瘤體錶層1/5部位見粉色典型螺鏇狀平滑肌組織結構、質地較軟,部分呈囊性變;子宮漿膜層、子宮肌層及子宮內膜外觀正常。術後病理檢查提示:瘤體組織為平滑肌組織或有透明變性,無噁性病變組織。結論:肌瘤的部位、瘤體血供及治療能量是影響HIFU療效的重要因素,箇體化治療是HIFU成功的原則,綵色多普勒檢測具有指導意義。
목적:분석단차정체체외초성소융치료자궁기류효과불가적원인화해결적판법。방법:대자궁기류단차정체고강도취초초성(HIFU)치료효과불가후행수술치료적5례환자치료자료급술중소견、술후조직병리검사결과진행회고성분석,병복습상관문헌。결과:본조HIFU치료평균공솔362~400 W、복조시간998~2947 s、치료제량398500.0J~1178800.0J、치료강도789~1091 s/h;HIFU치료후11~16개월증상개선불명현,핵자공진검사혹초성검사제시류체미명현축소혹초증대,HIFU치료후지수술시간위11~22개월;기중4례환자행자궁기류척제수술,1례환자행전자궁절제술。초성소견:자궁장막층광활,여분강장기、복막균무점련,수조자궁기류병조중심1/2~4/5구역균위회백색간락양혹유상배사,류체표층1/5부위견분색전형라선상평활기조직결구、질지교연,부분정낭성변;자궁장막층、자궁기층급자궁내막외관정상。술후병리검사제시:류체조직위평활기조직혹유투명변성,무악성병변조직。결론:기류적부위、류체혈공급치료능량시영향HIFU료효적중요인소,개체화치료시HIFU성공적원칙,채색다보륵검측구유지도의의。
Objective: To analyze the reasons and solutions for the ineffectiveness of single integral HIFU ablation in vitro for uterine fibroids. Methods: 5 cases of uterine fibroids treated by single integral HIFU ablation with poor outcome and subsequently treated by surgeries were analyzed retrospectively with regards to the HIFU treatment information, operative findings and post operational pathology. And the related literatures were reviewed. Results: In this group, the average power was 362W-400W, the radiation time was 998s-2947s, the treatment dose was 398500.0J-1178800.0J, and the treatment intensity was 789s/h-1091s/h; 11-16 months after HIFU, the symptom improvement was not obvious, MRI or US suggested that the tumor volume had not significantly decreased or increased slightly, the interval between HIFU treatment and surgery were 11-22 months; 4 patients had hysteromyomectomy and 1 had panhysterectomy. During operation, the uterine serosa were all smooth, had no adhesion with adjacent organs or peritoneum, 1/2-4/5 of the center area of the fibroids under radiation was gray caseous necrosis or emulsion necrosis, 1/5 of the tumor surface can see typical pink spiral smooth muscle tissue structure with soft texture, and part with cystic degeneration; the appearance of the serosa, myometrium and endometrium of the uterus were normal;postoperative pathologic examinations showed the tumor tissue was smooth muscle tissue or had hyaline degeneration, with no malignant tissues. Conclusion: The location of the fibroids, rich blood supply and the treatment dose are important factors that affect the efficacy of HIFU, individualized treatment is the principle of success, CDFI has instructive significance.